Anti-vascular endothelial growth factor therapy in polypoidal choroidal vasculopathy. [PDF]
Giridhar A, Lekha T, Chandran K.
europepmc +1 more source
Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study. [PDF]
Teo KYC +24 more
europepmc +1 more source
Comparison of Choroidal Morphological Changes Between Aflibercept 8 mg and Faricimab-svoa in Treatment-Naïve Polypoidal Choroidal Vasculopathy and Pachychoroid Neovasculopathy. [PDF]
Jeong S, Seong SH, Sagong M.
europepmc +1 more source
Peripheral polypoidal choroidal vasculopathy
Tingkun Shi, Haoyu Chen
doaj +1 more source
Choroidal changes correlate with type 1 neovascular activity in neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. [PDF]
Huang X +7 more
europepmc +1 more source
Polypoidal choroidal vasculopathy invading the optic disc
Alessandro Marchese +2 more
doaj +1 more source
Clinical Outcomes of High-Dose Aflibercept 8 mg in Polypoidal Choroidal Vasculopathy: A Systematic Review and Meta-Analysis. [PDF]
Bousamri A +6 more
europepmc +1 more source
Associations of <i>TNFRSF10A</i> with Central Serous Chorioretinopathy, Polypoidal Choroidal Vasculopathy, and Age-Related Macular Degeneration. [PDF]
Chen ZJ +10 more
europepmc +1 more source
Peripheral exudative hemorrhagic chorioretinopathy as a variant of polypoidal choroidal vasculopathy in a case series of Chinese patients. [PDF]
Wang JX, Zhou N, Yang LH, Wei WB.
europepmc +1 more source
Predictors of response to bevacizumab monotherapy in polypoidal choroidal vasculopathy: a 12-month retrospective study. [PDF]
Montrisuksirikun C +6 more
europepmc +1 more source

